Viking Therapeutics, Inc. (VKTX) stock closed at $47.03, down 1.75%, underperforming the medical sector

From Nasdaq: 2024-12-13 17:45:17

In the latest trading session, Viking Therapeutics, Inc. (VKTX) closed at $47.03, down 1.75%. The Dow fell by 0.2%, while the Nasdaq rose by 0.12%. VKTX stock has dropped by 10.64% in the past month, underperforming the Medical sector’s loss of 4.31%.

Analysts are closely watching Viking Therapeutics, Inc.’s upcoming earnings report. The projected EPS is -$0.27, an 8% decrease from the previous year. Recent analyst estimate changes indicate fluctuations in business trends and profitability, impacting stock performance.

Investors can benefit from using the Zacks Rank, which ranges from #1 (Strong Buy) to #5 (Strong Sell). VKTX currently holds a Zacks Rank of #3 (Hold). The Medical – Biomedical and Genetics industry has a Zacks Industry Rank of 67, placing it in the top 27% of industries.

The clean energy sector is experiencing significant growth as technology advances. Trillions of dollars are being invested in clean energy initiatives, offering potential for substantial stock gains. Discover emerging clean energy stocks with massive upside potential.

Download the free report “Nuclear to Solar: 5 Stocks Powering the Future” to explore Zacks’ top picks in the clean energy sector. Stay updated on the latest stock recommendations from Zacks Investment Research to make informed investment decisions. For more information and analysis, visit Zacks.com.



Read more at Nasdaq: Viking Therapeutics, Inc. (VKTX) Stock Moves -1.75%: What You Should Know